NovaDel Pharma (NVD) Names Zodda as Interim CFO
More News related to NVD
- NovaDel Pharma (NVD) Announces Voluntary Delisting from NYSE Amex
- NovaDel Announces Voluntary Delisting from NYSE Amex LLC and Pending Transfer to the Over-the-Counter Bulletin Board
- Novadel Pharma Inc. (NVD) Posts Q3 Loss of 2c, In-Line with Views
- Novadel Pharma Inc. (NVD) Posts Q3 Loss of 2c, In-Line with Views
- NovaDel Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2009
More News related to Management Changes
- Xerox (XRX) Closes $2B Unsecured Senior Note Offering
- American Water Works (AWK) Closes $60M Debt Offering
- ZIOPHARM Oncology (ZIOP) Prices 15.5M Common and 7.74M Warrant Offering at $3.10/Unit
- Regency Centers (REG) Prices 8M Common Offering at $30.75/Share
- Western Gas (WES) Prices 6M Common Unit Offering at $18.20/Unit
NovaDel Pharma Inc. (NYSE: NVD) today announced Michael Spicer’s resignation, effective April 1, 2009, as CFO and Corporate Secretary of the Company, in order to accept a position at another company.
Deni Zodda, Ph.D., the Company’s Chief Business Officer, has been appointed Interim CFO and Corporate Secretary.
Related Categories
Management ChangesStocks Mentioned
-0.07Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
